Spruce Street Capital LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0002050194

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q3 2026 Q2 2026 Q1 2026 Q4 2025

Q3 2026 · 38 positions · Total reported value $628.98M · Top-10 concentration 64.0% · Updated 2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

Turnover: 21.1% · 8 new · 0 cut · 0 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -10.9% · vs SPY -13.0% · Prev Value $509.68M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -0.4% · vs SPY -2.5% · Latest Value $628.98M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, Spruce Street Capital LP disclosed 38 equity positions with a combined reported value of $628.98M. The filing implies a focused portfolio: its ten largest positions account for 64.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were KNSA ($68.50M), LBRX ($53.86M), RLAY ($53.86M). By sector, the heaviest allocations are Health Care 96.3%, Financials 2.3%. Versus the prior quarter, allocation shifted toward Other (+1.5pp) and away from Health Care (-1.3pp).

Versus the prior quarter, Spruce Street Capital LP opened 8 new positions, trimmed 0 and fully exited 0, a turnover rate of 21.1% of positions. The portfolio's overlap with the prior quarter was 79% of names.

The largest new positions opened in Q3 2026 were ENTX ($32.63M), VRDN ($17.16M), SGMT ($13.83M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • ENTX ENTERA BIO LTD · $32.63M
  • VRDN VIRIDIAN THERAPEUTICS INC · $17.16M
  • SGMT SAGIMET BIOSCIENCES INC · $13.83M
  • DARE YARROW BIOSCIENCE INC · $13.68M
  • ANIX KORSANA BIOSCIENCES INC · $10.30M
  • RACD RESEARCH ALLIANCE CORP IV · $5.40M
  • ATOS ATTOVIA THERAPEUTICS INC · $3.91M
  • TLGYF TCGX ACQUISITION CORP · $3.75M

Fully Exited (vs previous quarter)

No tracked position was fully exited this quarter.

Insider Transactions (Form 4)

Latest Spruce Street Capital LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Spruce Street Capital LP is an SEC-registered 13F filer based in New York, NY, United States. As of Q2 2026 it reported 30 US equity positions with a combined value of $509.68M. HoldingsHub carries 3 quarters of its filings (Q4 2025–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-132577 (status: Approved), registered 2025-04-28
  • Regulatory AUM (Form ADV): $555.90M as of 2026-03-02
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 3 private funds, of which 3 hedge funds

Portfolio Structure

  • 30 positions · $509.68M reported value (Q2 2026)
  • Top 10 holdings = 70.2% of reported value
  • Largest position: KNSA (KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A) at 11.5%
  • Average position size: $16.99M

Sector Tilt

  • Health Care 97.5%
  • Financials 2.5%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 5 new, 8 added, 1 reduced, 3 exited
  • 16 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall direction and market view: The fund is actively increasing exposure to biotech/healthcare, with significant new positions and share additions, suggesting a bullish stance on innovative therapeutics despite volatility. 2. Key moves: - Added: LBRX (+2.1% shares), ANRO (+23.9%), ALKS (+74.4%), SVRA (+55.9%), ZLAB (+273.4%), RLMD (+8.1%). - New: ENTX (11.2M shares). - Reduced: None (all "Hold" or "Add" actions). 3. Portfolio structure: Highly active, concentrated in healthcare (100% of top 10), with high risk appetite (small-cap biotech focus, volatile share changes). 4. Per-holding one-liner: - KNSA: Kiniksa Pharmaceuticals (autoimmune/inflammatory diseases). - LBRX: LB Pharmaceuticals (generic drugs). - RLAY: Relay Therapeutics (cancer drug discovery). - ANRO: Alto Neuroscience (CNS disorders). - ALKS: Alkermes (addiction/psychiatry treatments). - ENTX: Entera Bio (gut-brain axis therapies, unverified). - DNTH: Dianthus Therapeutics (kidney diseases, unverified). - SVRA: Savara (respiratory diseases). - ZLAB: Zai Lab (oncology/immunology). - RLMD: Relmada Therapeutics (pain/cancer, unverified). 5. Style summary: Aggressive biotech investor doubling down on high-growth clinical-stage companies with explosive share additions.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-16 16:49

Sector Allocation

Health Care 96.3%
Financials 2.3%
Other 1.5%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 918.07K $68.50M 10.89%
10.89%
Hold
2 2.98M $53.86M 8.56%
8.56%
Hold
3 1.40M $53.86M 8.56%
8.56%
Add
4 1.68M $42.80M 6.80%
6.80%
Add
5 948.47K $38.43M 6.11%
6.11%
Add
6 11.21M $32.63M 5.19%
5.19%
New
7 354.82K $31.24M 4.97%
4.97%
Hold
8 5.38M $27.77M 4.42%
4.42%
Add
9 1.04M $27.45M 4.36%
4.36%
Add
10 6.91M $26.06M 4.14%
4.14%
Add
11 306.05K $17.41M 2.77%
2.77%
Hold
12 1.25M $17.16M 2.73%
2.73%
New
13 329.01K $15.08M 2.40%
2.40%
Hold
14 1.09M $14.35M 2.28%
2.28%
Hold
15 432.04K $13.90M 2.21%
2.21%
Hold
16 1.40M $13.83M 2.20%
2.20%
New
17 607.38K $13.68M 2.17%
2.17%
New
18 6.09M $10.96M 1.74%
1.74%
Add
19 338.95K $10.30M 1.64%
1.64%
New
20 3.69M $10.16M 1.61%
1.61%
Hold
21 1.75M $9.32M 1.48%
1.48%
Add
22 3.58M $7.36M 1.17%
1.17%
Hold
23 2.20M $6.97M 1.11%
1.11%
Hold
24 4.06M $6.94M 1.10%
1.10%
Hold
25 422.54K $6.19M 0.98%
0.98%
Hold
26 736.64K $5.96M 0.95%
0.95%
Hold
27 1.66M $5.55M 0.88%
0.88%
Hold
28 500.00K $5.42M 0.86%
0.86%
Hold
29 450.00K $5.40M 0.86%
0.86%
New
30 500.00K $5.31M 0.84%
0.84%
Hold
31 228.29K $3.91M 0.62%
0.62%
New
32 2.10M $3.89M 0.62%
0.62%
Hold
33 300.00K $3.75M 0.60%
0.60%
New
34 310.00K $3.45M 0.55%
0.55%
Add
35 928.59K $3.14M 0.50%
0.50%
Hold
36 392.57K $2.90M 0.46%
0.46%
Hold
37 231.59K $2.67M 0.42%
0.42%
Hold
38 393.70K $1.41M 0.22%
0.22%
Hold

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q4) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q3)

P 80% R 80% F1 80% (modelled on 2026-Q2; 8/10 hit)

Low-confidence forecast This fund replaces about 23% of its Top-10 each quarter and backtests at F1 75% (threshold 80%). Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.

Historical Backtest (2 quarters)

Avg precision 75% · recall 75% · F1 75% · avg rank error 2.0 · Top-10 turnover 23%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2026-Q2 70% 70% 70% RLMD · KNSA · LBRX · DNTH · ANRO · RLAY · CNTA · KALV · SVRA · ENTA KNSA · RLAY · LBRX · RLMD · ANRO · DNTH · ALKS · SVRA · PCVX · ELVN
2026-Q3 ★ 80% 80% 80% KNSA · RLAY · RLMD · LBRX · ANRO · DNTH · ALKS · SVRA · ENTA · PCVX KNSA · LBRX · RLAY · ANRO · ALKS · ENTX · DNTH · SVRA · ZLAB · RLMD

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

Barra Factor Attribution

The disclosed long US equity book from the 2026-Q3 13F is held at its report-date weights and decomposed over 2026-09-30 ~ 2026-11-13. The model uses 16 Barra style factors plus GICS sector dummies, WLS cross-sectional factor returns and an EWMA factor covariance for risk. The “portfolio” is the visible 13F book, not the fund's true NAV.

13F periodQ3 2026 Attribution quarterQ4 2026 (in progress) Window2026-09-30 → 2026-11-13 Trading days32 Holdings2 Model coverage100.0%

The quarter is not complete yet; the window ends at the latest available price date, 2026-11-13, and will update as prices arrive.

Portfolio return+1.17%Buy & hold
QQQ synthetic benchmark-13.72%Liquidity weighted
Excess return+14.89%vs benchmark
Barra annualised vol72.7%Model estimate
Realised vol70.9%Annualised in window
Weighted beta1.58Raw exposure
Factor / specific risk42% / 58%Share of variance
Top-10 concentration100.0%Of reported value
Portfolio value (start = 100)77.687.096.4105.7115.110-0110-2311-13Spruce Street Capital LPQQQ syntheticLiquid universe EW
Start = 100. Red = portfolio, dark = QQQ synthetic benchmark, dashed grey = equal-weight model universe.

1. Performance

Metric Value Note
Portfolio return (buy & hold)+1.17%Disclosed long book
QQQ synthetic benchmark-13.72%Liquidity-weighted constituents
Model universe, equal weight+0.30%Opportunity-cost reference
Excess return+14.89%Portfolio − benchmark
Arithmetic return sum+4.24%Difference vs compounded is the cross term
Weighted raw beta1.58Weighted holding betas
Realised volatility (annualised)70.90%Daily returns in window
Barra model volatility (annualised)72.71%Factor + specific
Factor share of variance41.6%Barra factors
Specific share of variance58.4%Stock residuals
Reported value$67.7M13F long US equity

2. Return attribution

The +4.24% arithmetic return splits into style factors, sector factors and specific return; the table is sorted by contribution.

Factor group Factors Contribution Share of |return|
Size & Liquidity 6 -2.39% -56.4%
Momentum & Growth 3 -10.95% -258.3%
Volatility & Tail Risk 7 +0.00% 0.0%
Industry 12 +8.12% 191.6%
Specific 1 +9.46% 223.1%
Return attribution (style + industry, %)-11.5-5.8+0.0+5.8+11.5Short-term Reversal+0.67Growth-0.96Leverage (Downside Vol)-1.05Amihud Illiquidity-1.11Non-linear Size+2.81Turnover-2.98Size+3.04Kurtosis-3.47Beta+3.58Mid Cap-4.52Historical Volatility-6.61Residual Volatility+7.24Health Care+8.12Momentum-10.67
Factor Type Exposure Factor return Contribution Share of |return|
Specific Specific — — +9.46% 223.1%
Health Care Industry +1.00 +8.12% +8.12% 191.6%
Residual Volatility Style +2.72 +2.66% +7.24% 170.7%
Beta Style +0.74 +4.85% +3.58% 84.4%
Size Style -1.66 -1.83% +3.04% 71.6%
Non-linear Size Style +3.07 +0.91% +2.81% 66.2%
Short-term Reversal Style +0.86 +0.79% +0.67% 15.9%
Skewness Style -0.10 -4.21% +0.41% 9.7%
Liquidity Style +1.74 +0.22% +0.37% 8.8%
Max Drawdown Style +0.04 -1.96% -0.08% -1.9%
Growth Style -0.61 +1.57% -0.96% -22.6%
Leverage (Downside Vol) Style +0.58 -1.82% -1.05% -24.9%
Amihud Illiquidity Style +2.75 -0.40% -1.11% -26.2%
Turnover Style +0.62 -4.77% -2.98% -70.3%
Kurtosis Style -0.50 +6.97% -3.47% -81.9%
Mid Cap Style +2.67 -1.69% -4.52% -106.7%
Historical Volatility Style +0.51 -12.86% -6.61% -156.0%
Momentum Style +3.20 -3.34% -10.67% -251.7%

3. Risk attribution

Annualised volatility is 72.71%; factor risk explains 41.6% of variance and specific risk 58.4%. A negative variance contribution means the factor is negatively correlated with the rest of the book and acts as a partial hedge.

Risk attribution (share of variance, %)-63.1-31.6+0.0+31.6+63.1Growth-1.64Turnover+0.26Leverage (Downside Vol)+0.44Amihud Illiquidity+1.24Short-term Reversal+1.48Size+2.73Liquidity+3.39Beta+4.38Mid Cap+5.00Health Care+5.44Residual Volatility+6.93Momentum+11.80Specific+58.44
Factor Type Exposure Share of variance Vol contribution Share of vol
Specific Specific — 58.4% +42.49% 42.5%
Momentum Style +3.20 11.8% +8.58% 8.6%
Residual Volatility Style +2.72 6.9% +5.04% 5.0%
Health Care Industry +1.00 5.4% +3.95% 4.0%
Mid Cap Style +2.67 5.0% +3.64% 3.6%
Beta Style +0.74 4.4% +3.19% 3.2%
Liquidity Style +1.74 3.4% +2.46% 2.5%
Size Style -1.66 2.7% +1.98% 2.0%
Short-term Reversal Style +0.86 1.5% +1.07% 1.1%
Amihud Illiquidity Style +2.75 1.2% +0.90% 0.9%
Leverage (Downside Vol) Style +0.58 0.4% +0.32% 0.3%
Turnover Style +0.62 0.3% +0.19% 0.2%
Growth Style -0.61 -1.6% -1.19% -1.2%

4. Style exposures

Standardised z-scores; positive means the book leans toward that style versus the model universe, negative means underweight.

Style exposures (z-score)-2.1-0.70.82.23.7Max DrawdownKurtosisSkewnessLeverage (Downside Vol)GrowthTurnoverAmihud IlliquidityLiquidityHistorical VolatilityResidual VolatilityShort-term ReversalMomentumBetaMid CapNon-linear SizeSizePortfolioQQQ benchmark
Style factor Portfolio QQQ benchmark Difference
Size -1.66 +2.10 -3.76
Non-linear Size +3.07 +1.68 +1.39
Mid Cap +2.67 +0.13 +2.54
Beta +0.74 +1.29 -0.56
Momentum +3.20 +0.72 +2.48
Short-term Reversal +0.86 -0.64 +1.50
Residual Volatility +2.72 -0.40 +3.12
Historical Volatility +0.51 +0.86 -0.35
Liquidity +1.74 +0.11 +1.62
Amihud Illiquidity +2.75 +1.16 +1.60
Turnover +0.62 +0.21 +0.42
Growth -0.61 +0.58 -1.19
Leverage (Downside Vol) +0.58 +0.14 +0.43
Skewness -0.10 +0.24 -0.33
Kurtosis -0.50 +0.21 -0.71
Max Drawdown +0.04 -0.08 +0.12

5. Industry allocation & Brinson

Industry allocation (weight, %)-10.020.050.080.0110.0Information TechnologyCommunication ServicesUtilitiesConsumer StaplesConsumer DiscretionaryIndustrialsHealth CarePortfolioQQQ benchmark
Sector Portfolio Benchmark Portfolio ret Benchmark ret Allocation Selection Interaction Total
Information Technology 0.0% 73.6% +0.00% -19.18% +4.32% +14.12% -14.12% +14.12%
Health Care 100.0% 1.7% +0.88% +9.16% +22.08% -0.14% -8.14% +0.72%
Communication Services 0.0% 2.6% +0.00% -15.54% +0.06% +0.41% -0.41% +0.41%
Utilities 0.0% 0.8% +0.00% +11.58% -0.20% -0.09% +0.09% -0.09%
Consumer Staples 0.0% 0.8% +0.00% +15.58% -0.24% -0.13% +0.13% -0.13%
Consumer Discretionary 0.0% 8.8% +0.00% +5.56% -1.66% -0.49% +0.49% -0.49%
Industrials 0.0% 11.1% +0.00% +7.16% -2.27% -0.80% +0.80% -0.80%
Total +21.99% +12.84% -21.12% +13.71%

6. Holdings & contribution

Symbol Name Sector Weight Return Contribution QoQ
RLAY RELAY THERAPEUTICS INC Health Care 79.57% +0.22% +0.18% Hold
SGMT SAGIMET BIOSCIENCES INC Health Care 20.43% +3.44% +0.70% New
Contribution rank Symbol Sector Weight Return Contribution
1 SGMT Health Care 20.43% +3.44% +0.70%
2 RLAY Health Care 79.57% +0.22% +0.18%

7. Conclusions

  1. Over the attribution window 2026-09-30 → 2026-11-13 (32 trading days), the reported portfolio returned +1.17%, versus -13.72% for the QQQ synthetic benchmark — an excess of +14.89%.
  2. Return attribution: the largest positive style/industry contributions came from Health Care +8.12%, Residual Volatility +7.24%, Beta +3.58%; the largest drags came from Momentum -10.67%, Historical Volatility -6.61%, Mid Cap -4.52%. Specific (stock-level) return contributed +9.46%.
  3. Risk attribution: Barra model volatility is 72.71% annualised; factor risk explains 42% of variance and specific risk 58%. The largest factor risk sources are Momentum 11.8%, Residual Volatility 6.9%, Health Care 5.4%.
  4. Style tilt: size -1.66, momentum +3.20, volatility +0.51, liquidity +1.74; the weighted raw beta is 1.58. Positive z-scores mean the portfolio leans toward that style versus the cross-section.
  5. Industry: the largest overweight versus the benchmark is Health Care (+98.3 pp), the largest underweight is Information Technology (-73.6 pp). Allocation contributed +21.99%, selection +12.84% and interaction -21.12%.
  6. Concentration: the top-10 positions are 100.0% of the attributed portfolio and the model covers 100.0% of its value with full style exposures. This is a high-conviction, long-only 13F book — not the fund's complete NAV.
Methodology & caveats
  • 13F discloses long US equity (including some options) only; cash, shorts and non-US positions are absent. This is not the fund's true NAV.
  • Weights are the report-date reported values and stay fixed over the window (buy & hold); intra-quarter trading and flows are not captured.
  • Factor exposures are measured at quarter end and held through the next quarter; style factors are cross-sectionally orthogonalised and read as incremental exposures.
  • The database has no share-count data, so size and liquidity use dollar volume (price × volume) as a proxy; Size is closer to “traded-value scale”.
  • Factor returns come from a WLS cross-sectional regression on the model universe; risk is annualised, and some factor variance contributions can be negative.
  • 13F filings lag by up to 45 days, so the stretch from the report date to the filing date was not actionable in real time.
  • Sector mapping uses one consistent GICS level-1 scheme for both the portfolio and the benchmark.

FAQ

What did Spruce Street Capital LP buy in 2026-Q3?

In its 2026-Q3 13F filing, Spruce Street Capital LP reported 38 equity positions worth $628.98M in aggregate; its largest disclosed positions were KNSA ($68.50M), LBRX ($53.86M), RLAY ($53.86M).

How large is Spruce Street Capital LP's portfolio?

Spruce Street Capital LP reported $628.98M of long equity holdings across 38 positions as of 2026-Q3. Top-10 holdings account for 64.0% of reported value.

What is Spruce Street Capital LP's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/spruce-street-capital/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →